* Says Morphosys and Galapagos start
first-in-patient dosing of IL-17C antibody MOR106 in atopic
dermatitis
The post BRIEF-Morphosys, Galapagos start first-in-patient dosing of IL-17C antibody MOR106 in atopic dermatitis appeared first on NASDAQ.
Forex – financial instrument.Forex news
* Says Morphosys and Galapagos start
first-in-patient dosing of IL-17C antibody MOR106 in atopic
dermatitis
The post BRIEF-Morphosys, Galapagos start first-in-patient dosing of IL-17C antibody MOR106 in atopic dermatitis appeared first on NASDAQ.